Trulieve Cannabis (TRLV) Notes Payables (2020 - 2026)

Trulieve Cannabis has reported Notes Payables for 7 years, with the latest figure at $4.2 million in Q2 2026.

• On a quarterly basis, Notes Payables rose 13.98% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $4.2 million, a 13.98% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 19.67% from the prior year.
• Notes Payables was $4.2 million for Q2 2026 at Trulieve Cannabis, up from $4.1 million in the prior quarter.
• The five-year high for Notes Payables was $12.5 million in Q4 2022, with the low at $3.3 million in Q3 2024.
• Average Notes Payables over 5 years is $5.9 million, with a median of $4.1 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Notes Payables surged 374.05% in 2022, then slumped 69.81% in 2023.
• Over 5 years, Notes Payables stood at $12.5 million in 2022, then plunged by 69.81% to $3.8 million in 2023, then dropped by 9.36% to $3.4 million in 2024, then advanced by 19.67% to $4.1 million in 2025, then rose by 2.58% to $4.2 million in 2026.
• The last three Notes Payables figures came in at $4.2 million (Q2 2026), $4.1 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.